U.S. market Closed. Opens in 11 hours 22 minutes

UBX | Unity Biotechnology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/A236.00K4.78MN/AN/AN/A1.38MN/A
Cost of Revenue1.18M2.18M2.88M3.45M2.66MN/AN/AN/A
Gross Profit-1.18M-1.94M1.90M-3.45M-2.66MN/AN/AN/A
Operating Expenses38.98M57.81M61.45M91.33M91.00M74.92M46.99MN/A
Selling, General & Admin18.18M20.95M23.06M24.02M20.05M16.02M9.62M5.14M
Research & Development20.80M36.86M38.39M67.31M70.96M58.91M37.37M13.71M
Other Operating Expenses5.60M-17.00K-983.00K182.00K4.18M-245.00KN/AN/A
Operating Income-40.16M-57.57M-56.66M-93.93M-89.65M-79.47M-45.61M-18.84M
Other Expenses / Income305.00K-2.35M-4.06M86.00K7.47M-4.79M952.00K-11.56M
Before Tax Income-39.86M-59.93M-60.73M-93.84M-82.18M-76.40M-44.66M-30.40M
Income Tax ExpensesN/A-2.18M-686.00K-1.98M-7.30M3.07MN/AN/A
Net Income-39.86M-57.75M-60.04M-91.87M-74.87M-76.40M-44.66M-30.40M
Interest Expenses-2.45M3.56M3.18M1.29MN/A3.31MN/AN/A
Basic Shares Outstanding14.77M9.49M5.58M5.09M4.36M2.83M3.00M3.44M
Diluted Shares Outstanding14.77M9.49M5.58M5.09M4.36M2.83M3.00M3.44M
EBITDA-38.98M-56.37M-57.55M-89.96M-92.36M-70.38M-43.35M-9.31M
EBITDA Margin0.00%-23,885.17%-1,202.93%0.00%0.00%0.00%-3,136.90%0.00%
EBIT-42.31M-56.37M-57.55M-92.55M-82.18M-70.02M-44.66M-30.40M
EBIT Margin0.00%-23,885.17%-1,202.93%0.00%0.00%0.00%-3,231.26%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙